Last reviewed · How we verify
Freeze-Dried Black Raspberry Powder
At a glance
| Generic name | Freeze-Dried Black Raspberry Powder |
|---|---|
| Sponsor | Ehab L Atallah |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Prevention of Oral DNA Damage by Black Raspberries (NA)
- Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) (PHASE2)
- Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors (NA)
- Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Freeze-Dried Black Raspberry Powder CI brief — competitive landscape report
- Freeze-Dried Black Raspberry Powder updates RSS · CI watch RSS
- Ehab L Atallah portfolio CI